title: Phase II study of single-agent cetuximab in KRAS G13D mutant metastatic colorectal cancer.
authors.affiliation: Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana and Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa.
authors.forename: M
authors.initials: M
authors.lastname: Schirripa
authors.affiliation: Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana and Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa fotiosloupakis@gmail.com.
authors.forename: F
authors.initials: F
authors.lastname: Loupakis
authors.affiliation: Unit of Medical Oncology 1, Oncology Institute of Veneto-IRCCS, Padova, Italy.
authors.forename: S
authors.initials: S
authors.lastname: Lonardi
authors.affiliation: Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana and Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa.
authors.forename: C
authors.initials: C
authors.lastname: Cremolini
authors.affiliation: Unit of Medical Oncology 1, Oncology Institute of Veneto-IRCCS, Padova, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Bergamo
authors.affiliation: Unit of Medical Oncology 1, Oncology Institute of Veneto-IRCCS, Padova, Italy.
authors.forename: V
authors.initials: V
authors.lastname: Zagonel
authors.affiliation: Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana and Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa.
authors.forename: A
authors.initials: A
authors.lastname: Falcone
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage*; D000068818:Cetuximab / Q000008:administration & dosage*; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D018572:Disease-Free Survival; D006801:Humans; D009154:Mutation / Q000235:genetics*; D011446:Prospective Studies; D016283:Proto-Oncogene Proteins p21(ras) / Q000235:genetics*
chemical_list: D000970:Antineoplastic Agents; C117307:KRAS protein, human; D016283:Proto-Oncogene Proteins p21(ras); D000068818:Cetuximab